Cargando…

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma

Proteoglycans, which consist of a protein core and glycosaminoglycan chains, are major components of the extracellular matrix and play physiological roles in maintaining tissue homeostasis. In the carcinogenic tissue microenvironment, proteoglycan expression changes dramatically. Altered proteoglyca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Yasuo, Tateishi, Ryosuke, Koike, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213444/ https://www.ncbi.nlm.nih.gov/pubmed/30297672 http://dx.doi.org/10.3390/ijms19103070

Ejemplares similares

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
por: Yang, Heng, et al.
Publicado: (2021)

Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma
por: Alshehri, Mohammed A., et al.
Publicado: (2021)

Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)
por: Mikoshiba, Naoko, et al.
Publicado: (2012)

Development and prognosis of hepatocellular carcinoma in patients with diabetes
por: Nakatsuka, Takuma, et al.
Publicado: (2023)

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
por: Sato, Masaya, et al.
Publicado: (2019)

Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma
por: Dituri, Francesco, et al.
Publicado: (2022)

Proteoglycans—Biomarkers and Targets in Cancer Therapy
por: Nikitovic, Dragana, et al.
Publicado: (2018)

Proteoglycans as Therapeutic Targets in Brain Cancer
por: Yan, Zoya, et al.
Publicado: (2020)

Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
por: Sorop, Andrei, et al.
Publicado: (2021)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

BET Proteins as Attractive Targets for Cancer Therapeutics
por: Sarnik, Joanna, et al.
Publicado: (2021)

Proteoglycans as potential biomarkers in odontogenic tumors
por: Gómez-Herrera, Zaira, et al.
Publicado: (2018)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
por: Tateishi, Ryosuke, et al.
Publicado: (2014)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
por: Lanzi, Cinzia, et al.
Publicado: (2020)

In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database
por: Sato, Masaya, et al.
Publicado: (2019)

Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Wu, Linghong, et al.
Publicado: (2022)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
por: Nakagami, Yasuhiro
Publicado: (2016)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Proteoglycans and their functions in esophageal squamous cell carcinoma
por: Zhu, Yun, et al.
Publicado: (2021)

Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma
por: Chen, Long, et al.
Publicado: (2013)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
por: Yao, Min, et al.
Publicado: (2022)

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma
por: Shibata, Chikako, et al.
Publicado: (2013)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022)

Proteoglycans and Immunobiology of Cancer—Therapeutic Implications
por: Tzanakakis, George, et al.
Publicado: (2019)

Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
por: De Pasquale, Valeria, et al.
Publicado: (2018)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ul8ubscklo41o129k6sqo3blq5